A prototype magnetically suspended rotor ventricular assist device demonstrated promising hydraulic efficiency and low hemolysis in vitro, supporting its potential for long-term implantable use.
Answers are grounded in this paper and cite their sources.
Supports continued preclinical VAD development; leaves open translation of in vitro performance to chronic in vivo use.
A continuous flow centrifugal blood pump with magnetically suspended impeller has been designed, constructed, and tested. The system can be functionally divided into three subsystem designs: 1) centrifugal pump and flow paths, 2) magnetic bearings, and 3) brushless DC motor. The centrifugal pump is a Francis vane type design with a designed operating point of 6 L/min flow and 100 mmHg pressure rise at 2,300 RPM. Peak hydraulic efficiency is over 50%. The magnetic bearing system is an all active design with five axes of control. Rotor position sensors were developed as part of the system to provide feedback to a proportional-integral-derivative controller. The motor is a sensorless brushless DC motor. Back electromotive force voltage generated by the motor is used to provide commutation for the motor. No slots are employed in the motor design in order to reduce the radial force that the bearings must generate. Tests pumping blood in vitro were very encouraging; an index of hemolysis of 0.0086 +/- 0.0012 was measured. Further design refinement is needed to reduce power dissipation and size of the device. The concept of using magnetic bearings in a blood pump shows promise in a long-term implantable blood pump.
No takes yet. Share an insight, caveat, or question.
Bearnson et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: